Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Medicine information VEKLURY 100mg 5mg / ml concentrate for solution for infusion
- Product code:
- W67196001
- Quantity:
- 1
- Indicated for:
- COVID-19
- Route of administration:
- infusion
- Substance:
- remdesivir (antiviral)
- ATC
- J05AB16 — Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Remdesivir is an antiviral medication used for the treatment of SARS-CoV-2 infection, which causes COVID-19. It is a nucleotide analog that inhibits viral RNA polymerase, blocking the replication of the virus in infected cells. Remdesivir has been approved for use in moderate to severe cases of COVID-19, particularly in hospitalized patients requiring supplemental oxygen.
The medication is administered intravenously, usually once daily, for a duration of 5 to 10 days, depending on the severity of the disease. It is most effective when given in the early stages of infection, before the disease progresses to critical forms.
Common side effects include nausea, headache, elevated liver enzymes (transaminases), and injection site reactions. Rarely, severe allergic reactions or kidney dysfunction may occur. Regular monitoring of liver and kidney function is essential during treatment.
Remdesivir is used under strict medical supervision and is reserved for hospitals and medical facilities. While it can reduce hospitalization duration and disease progression, its effectiveness varies depending on the stage of the disease and the patient’s overall condition.
The medication is administered intravenously, usually once daily, for a duration of 5 to 10 days, depending on the severity of the disease. It is most effective when given in the early stages of infection, before the disease progresses to critical forms.
Common side effects include nausea, headache, elevated liver enzymes (transaminases), and injection site reactions. Rarely, severe allergic reactions or kidney dysfunction may occur. Regular monitoring of liver and kidney function is essential during treatment.
Remdesivir is used under strict medical supervision and is reserved for hospitals and medical facilities. While it can reduce hospitalization duration and disease progression, its effectiveness varies depending on the stage of the disease and the patient’s overall condition.
General data about VEKLURY 100mg 5mg / ml
- Substance:
- remdesivir
- Product code:
- W67196001
- Strength:
- 5mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for remdesivir
Strengths available for remdesivir
- 100mg
- 5mg/ml
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
- Added to database:
- 18/07/2020
- Source record updated:
- 06/01/2026
Warnings:
Major drug interactions
This medicine may have important interactions with other medicines.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.